학술논문
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
Document Type
Article
Author
Source
Subject
*GENETIC vectors
*ANTI-vaccination movement
*VIRAL vaccines
*VACCINE safety
*COVID-19
*VACCINES
*PROTEINS
*
*
*
*
*
*
Language
ISSN
0264-410X
Abstract
Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines. [ABSTRACT FROM AUTHOR]